Abstract 2744: Exploring the role of the MSLN/MUC16 interaction in cancer progression via the in situ proximity ligation technique

Abstract

Abstract Introduction: Mesothelin (MSLN) is a glycoprotein present on the surface of mesothelial cells, sometimes used as a tumor marker. Its overexpression in various cancers, including mesothelioma, ovarian, pancreatic, and lung, is linked to increased tumor aggressiveness, evasion of apoptosis, metastasis, and resistance to treatments. Mucin16 (MUC16) belongs to a family of proteins that play a crucial role in cell adhesion, signaling, and immune responses. In cancer, alterations in mucin expression and structure may contribute to tumor progression and metastasis by enhancing cell survival and immune evasion. Mesothelin is known to interact with mucins, influencing tumor cell behavior and metastatic potential. More specifically, the MSLN/MUC16 interaction facilitates tumor cell invasion and peritoneal spread in ovarian cancer. However, reliable molecular tools to study protein interactions have been scarce. Here, we relied on the Naveni® in situ proximity ligation technology to identify MSLN/MUC16 in various cancer samples. The method detects proteins located within interaction range (<40 nm) by means of antibodies conjugated to oligonucleotides that create amplified fluorescent signal. Since the technique does not compromise the structural integrity of tissues, communication between proteins can be studied in their native environment. Materials & Methods: Human FFPE tissue microarrays (TMA) with ovarian primary carcinoma and matched metastatic cancer (80 cores) and ovarian cancer tissue with normal tissue (100 cores) were deparaffinized and subjected to standard heat-induced antigen retrieval and blocking. Staining against the MSLN/MUC16 interaction was performed with the NaveniFlex Tissue MR Atto647N kit (Navinci Diagnostics). Co-staining antibodies against pan-Cytokeratin and Ki67 were included in the detection mix. Immunofluorescence (IF), using the same MSLN and MUC1 primary antibodies, was completed on an additional slide of each TMA, and then secondary antibodies conjugated to Alexa Fluor™ 488 and 594 were used for detection. Imaging was performed on an Olympus scanner VS200. Results & Discussion: In this study, we showed that the interaction is abundant in ovarian cancer, with a distinguishable difference in the signal presence between cancerous and normal adjacent tissue. Furthermore, the additional tumor marker co-stainings give insights into the tumor invasion and growth. When comparing the Naveni® signal of MSLN/MUC16 against IF staining of each, the Naveni® signal shows true interactions, as opposed to expression patterns. Understanding the roles of mesothelin and mucin in cancer, both individually and in interaction, is crucial for developing targeted therapies and diagnostic tools. Further research on their interaction and specific molecular pathways triggered by it is essential for devising effective strategies to combat cancer progression. Citation Format: Sara Bodbin, Doroteya Raykova, Agata Zieba-Wicher. Exploring the role of the MSLN/MUC16 interaction in cancer progression via the in situ proximity ligation technique [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 2744.